Public Meeting: Cosmetic Microbiological Safety
November 30, 2011
9:00 a.m. - 5: 30 p.m.
L'Enfant Plaza Hotel
480 L'Enfant Plaza S.W.
Washington, DC 20024-2253
The U.S. Food and Drug Administration (FDA) has announced a Public Meeting on Cosmetic Microbiological Safety Issues. The purpose of the Meeting is to provide stakeholders an opportunity to present information regarding cosmetic microbiological safety and to suggest areas for the possible development of FDA guidance documents. FDA is seeking information regarding microbiological testing of cosmetics; types of preservative systems and how to test their efficacy; the identity and prevalence of microorganisms, including antibiotic-resistant strains, that pose specific health risks in finished products; routes of exposure to microorganisms and the corresponding infective doses; product and packaging characteristics that affect microbial growth and risk of infection; particular subpopulations that may be at greater risk of infection when using different cosmetic products; the occurrence of adverse events associated with microbial contamination of cosmetics; and any other issues relevant to the microbiological safety of cosmetics.
Public Meeting attendees are encouraged to register on-line or contact: Courtney Treece, Planning Professionals, Ltd., 1210 W. McDermott, Suite 111, Allen, TX 75013, phone: 704-258-4983, fax: 469-854-6992, e-mail: firstname.lastname@example.org.
For general questions about the Meeting, to request an opportunity to make Oral Comments, or to request special accommodations due to a Disability, contact: Juanita Yates, Center for Food Safety and Applied Nutrition, Food and Drug Administration, 240-402-1731, e-mail: email@example.com.
Docket No. FDA-2011-N-0770
Please note the following important dates:
- November 10, 2011: Closing date for Request to Make Oral Presentation
- November 21, 2011: Closing date for:
- Advance Registration
- Requesting special accommodations due to a Disability, and
- Providing a brief description of an oral presentation and any written material for presentation
- January 30, 2012: Closing date to Submit either electronic or written comments to FDA's Division of Dockets Management